Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Jul 1, 2024
Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset and progressive development. AD is a health issue that is attracting attention as the world's populations get older. Although there is currently no effective treatment for t...
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
Jul 1, 2024
Alzheimer's Disease (AD), the most prevalent form of dementia, requires early prediction for timely intervention. Leveraging data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), our study employs Graph Neural Networks (GNNs) for multi-cl...
Development of deep learning models to evaluate structural brain changes caused by cognitive impairment in MRI scans holds significant translational value. The efficacy of these models often encounters challenges due to variabilities arising from dif...
Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi
Apr 25, 2024
Alzheimer's disease (AD) is a common and serious form of elderly dementia, but early detection and treatment of mild cognitive impairment can help slow down the progression of dementia. Recent studies have shown that there is a relationship between o...
BACKGROUND: In recent years, Virtual Reality (VR) has emerged as a promising tool to improve the well-being and functional capabilities of older adults. Although VR applications have shown positive results, their impact on user experience and therape...
American journal of Alzheimer's disease and other dementias
Jan 1, 2024
Alterations in Heart Rate (HR) and Heart Rate Variability (HRV) reflect autonomic dysfunction associated with neurodegeneration making them biomarkers suitable for detecting Mild Cognitive Impairment (MCI). The study involves 297 urban Indian parti...
American journal of Alzheimer's disease and other dementias
Jan 1, 2024
Several research studies have demonstrated the potential use of cerebrospinal fluid biomarkers such as amyloid beta 1-42, T-tau, and P-tau, in early diagnosis of Alzheimer's disease stages. The levels of these biomarkers in conjunction with the demen...
Advances in experimental medicine and biology
Jan 1, 2024
BACKGROUND: Recently, a method using deep learning has been developed to estimate the risk of developing dementia. This method uses general blood test data from routine health examinations that reveal lifestyle-related diseases, which can lead to vas...
With the advent of therapeutics with potential to slow Alzheimer's disease progression the necessity of understanding the diagnostic value of plasma biomarkers is critical, not only for understanding the etiology and progression of Alzheimer's diseas...